Sign in
4

Changes in Ownership

BOSTON SCIENTIFIC CORP Filed Acc 0001225208-25-006986

EVP & Group Pres, Cardiology sold 50,000 shares at $104.63 ($5,231,670)

  • EVP & Group Pres, Cardiology acquired 50,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Fitzgerald Joseph Michael · EVP & Group Pres, Cardiology

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-08-01 Exercise or conversion : show line 1 in the form 10b5-1 +50,000 $26.15 $1,307,500 228,342 D
2025-08-01 Sale : show line 2 in the form 10b5-1 −50,000 $104.63 $5,231,670 178,342 D
Open-market sales · 50,000 sh · avg $104.63 · $5,231,670

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-08-01 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) −50,000 150,000 D
Loading xslF345X05/doc4.xml…